Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: The Children's Hospital Los Angeles (CHLA) experience, 1991-2010

Pediatric Blood and Cancer

Volumn 58, Issue 6, 2012, Pages 905-909

  Gozali, Alexa E ^a,b   Britt, Barbara ^a   Shane, Lisa ^a   Gonzalez, Ignacio ^a,b   Gilles, Floyd ^a,b   Mccomb, J Gordon ^a,b   Krieger, Mark D ^a,b   Lavey, Robert S ^a,b   Shlien, Adam ^c   Villablanca, Judith G ^a,b   Erdreich Epstein, Anat ^a,b   Dhall, Girish ^a,b   Jubran, Rima ^a,b   Tabori, Uri ^c   Malkin, David ^c   Finlay, Jonathan L ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Choroid plexus tumors; Li Fraumeni syndrome

Indexed keywords

PROTEIN P53;

ADOLESCENT; ARTICLE; CARCINOMA; CHILD; CHILDHOOD CANCER; CHOROID PLEXUS CARCINOMA; CHOROID PLEXUS PAPILLOMA; CHOROID PLEXUS TUMOR; CLINICAL ARTICLE; DISEASE ASSOCIATION; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; INFANT; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHOROID PLEXUS NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GERM-LINE MUTATION; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; LI-FRAUMENI SYNDROME; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84858673081     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23349     Document Type: Article

References (23)

1. Wolff JE, Finlay JL. Choroid plexus tumors. In: Carroll WL, Finlay JL, editors. Cancer in children and adolescents. Massachusetts: Jones and Bartlett Publishers; 2009. p. 299.
2. Louis DN, Ohgaki H, Wiestler OD, et al., editors. World Health Organisation Classification of tumours. Pathology and genetics-tumours of the nervous system, 4th edition. Geneva: WHO Press; 2007. pp. 81-85.
3. Fitzpatrick LK, Aronson LJ, Cohen KJ. Is there a requirement for adjuvant therapy for choroid plexus carcinoma that has been completely resected? J Neurooncol 2002; 57: 123-126.
4. Garber JE, Goldstein AM, Kator AF, et al. Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 1991; 51: 6094-6097.
5. Olivier M, Goldgar DE, Sodha N, et al. Li-Fraumeni and related syndromes: Correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003; 63: 6643-6650.
6. Tabori U, Shlien A, Baskin B, et al. Genetic and genomic analysis determines the role of the p53 alterations in the management of choroid plexus carcinomas. J Clin Oncol 2010; 28: 1995-2001.
7. Judkins AR, Burger PC, Hamilton RL, et al. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol 2005; 64: 391-397.
8. Wolff JE, Sajedi M, Brant R, et al. Choroid plexus tumours. Br J Cancer 2002; 87: 1086-1091.
9. Pierga JY, Kalifa C, Terrier-Lacombe MJ, et al. Carcinoma of the choroid plexus: A pediatric experience. Med Pediatr Oncol 1993; 21: 480-487.
10. Packer RJ, Perilongo G, Johnson D, et al. Choroid plexus carcinoma of childhood. Cancer 1992; 69: 580-585.
11. Ellenbogen RG, Winston KR, Kupsky WJ. Tumors of the choroid plexus in children. Neurosurgery 1989; 25: 327-335.
12. Wrede B, Liu P, Wolff JEA. Chemotherapy improves the survival of patients with choroid plexus carcinoma; a meta-analysis of individual cases with choroid plexus tumors. J Neurooncol 2007; 85: 345-351.
13. Wolff JE, Sajedi M, Coppes MJ, et al. Radiation therapy and survival in choroid plexus carcinoma. Lancet 1999; 353: 2126.
14. Rutherford J, Chu CE, Duddy PM, et al. Investigations on a clinically and functionally unusual and novel germline p53 mutation. Br J Cancer 2002; 86: 1592-1596.
15. Yuasa H, Tokito S, Tokunaga M. Primary carcinoma of the choroid plexus in Li-Fraumeni syndrome: Case report. Neurosurgery 1993; 32: 131-133.
16. Krutilkova V, Trakova M, Fleitz J, et al. Identification of five new families strengthens the link between childhood choroids plexus carcinoma and germline TP53 mutations. Eur J Cancer 2005; 41: 1597-1603.
17. Tinat J, Bougeard G, Baert-Desurmont S, et al. Version of the Chompret criteria for Li-Fraumeni syndrome. J Clin Oncol 2009; 27: e108-e109.
18. Wang L, Conford ME. Coincident choroid plexus carcinoma and adrenocortical carcinoma with elevated p53 expression. Arch Pathol Lab Med 2002; 126: 70-72.
19. Kleihues P, Schauble B, zur Hausen A, et al. Tumors associated with p53 germline mutations: A synopsis of 91 families. Am J Pathol 1997; 150: 1-13.
20. Tijseen CC, Halprin MR, Enditz LJ, editors. Familial choroid plexus papilloma. In: Familial brain tumours. A commentated register. Massachusetts: M. Nijhoff Pubs; 1982. pp. 143-168.
21. Gonzalez KD, Noltner KA, Buzin CH, et al. Beyond Li-Fraumeni syndrome: Clinical characteristics of families with p53 germline mutations. J Clin Oncol 2009; 27: 1250-1256.
22. Becherini M, Castangna A, Iannelli C, et al. Choroid plexus carcinoma: A new case associated with a novel TP53 germ line mutation. Neuropathol Appl Neurobiol 2008; 34: 564-568.
23. Villani A, Tabori U, Schiffman J, et al. Impact of early detection strategies on cancer mortality in germline TP53 mutations carriers in Li-Fraumeni syndrome. Lancet Oncol 2011; 12: 559-567.